Article info
Hepatology
Original article
Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2−/−
mice by modulating composition, signalling and excretion of faecal bile acids
- Correspondence to Professor Michael Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna 1090, Austria; michael.trauner{at}meduniwien.ac.at
Citation
Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2−/−
mice by modulating composition, signalling and excretion of faecal bile acids
Publication history
- Received May 24, 2017
- Revised February 20, 2018
- Accepted March 3, 2018
- First published April 10, 2018.
Online issue publication
November 24, 2018
Article Versions
- Previous version (24 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/